Amalgamation effective November 01, 2026; Record Date November 18, 2026 for consideration shares
Board noted the Scheme of Amalgamation becomes effective and operative from November 01, 2026.
By ScoutQuest · · 2 min read
- Effective Date
- November 01, 2026
- Appointed Date
- April 01, 2026
- Share Exchange Ratio
- 23 equity shares of Dr. Agarwal's Health Care Ltd (face value ₹1 each) for every 2 equity shares of Dr. Agarwal's Eye Hospital Ltd (face…
- Record Date
- November 18, 2026
Scheme becomes effective
The Board of Dr. Agarwal's Eye Hospital Ltd took on record the certified copy of the order dated September 30, 2026 passed by the NCLT, Chennai Bench, sanctioning the Scheme of Amalgamation with Dr. Agarwal's Health Care Ltd. The certified copy was shared in Form INC-28 with the Registrar of Companies on October 14, 2026, and the Board noted that all conditionalities under Clause 24 of the Scheme stand satisfied.
The Scheme shall become effective and operative from November 01, 2026, with the Appointed Date being April 01, 2026.
What shareholders receive
- 23 fully paid-up equity shares of face value of ₹1 each of Dr. Agarwal's Health Care Ltd for every 2 fully paid-up equity shares of face value of ₹10 each held in Dr. Agarwal's Eye Hospital Ltd.
- The Board has fixed Wednesday, November 18, 2026 as the Record Date for determining the eligible equity shareholders of the company entitled to receive these consideration shares.
What happens to the company
- Once the Scheme becomes effective on November 01, 2026, Dr. Agarwal's Eye Hospital Ltd shall stand dissolved without being wound-up.
- With effect from that date, the Board of Directors of the company ceases to exist, and the company's status changes to Amalgamated as per the records of the Registrar of Companies.
Reading the share exchange ratio
The ratio fixes how many shares of the transferee company a shareholder gets for the shares held in the transferor company. The face values differ: the shares being cancelled carry a face value of ₹10 each, while the shares being issued carry a face value of ₹1 each. The ratio of 23 for every 2 is the operative conversion, and eligibility is decided by holdings on the Record Date.
What the update records
This is the final step of the scheme process described in the update, following the NCLT sanction intimated on October 05, 2026. The company has set out the effective date, the appointed date, the Record Date and the exchange ratio, and has recorded the dissolution of the transferor company and its Board on the effective date.
Also from Dr Agarwals Eye Hospital
Record Date for amalgamation share allotment fixed as November 18, 2026
20 Oct 2026
NCLT Chennai sanctions scheme of amalgamation; appointed date April 01, 2026, effective date tied to conditions
5 Oct 2026
More numbers
- Consideration shares of Dr. Agarwal's Health Care Ltd per 2 shares held23
- Shares of Dr. Agarwal's Eye Hospital Ltd for the exchange ratio2
- Face value per equity share of Dr. Agarwal's Health Care Ltd₹1
- Face value per equity share of Dr. Agarwal's Eye Hospital Ltd₹10
Nothing here is a view, opinion or recommendation of ScoutQuest, its parent, directors or employees. ScoutQuest is a technology company: this page was assembled automatically from public sources using artificial intelligence, and may contain errors or omissions. Confirm everything against the original source before you act on it. Any use of this page is at your own risk, and neither ScoutQuest nor its parent, directors or employees accepts liability for it.